2,6-Di(1H-pyrazol-1-yl)-4,4'-bipyridine, 98%, 100mg

METHYL (S)-PYRROLIDIN-3-YL-ACETATE HCL, 97.0%, 250mg

Tetrabutylammonium Dibromoiodide>97.0%(T)1g

Phenyl(pyrrolidin-3-yl)methanone, 98%, 1g

6-METHYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE, 97.0%, 250mg

(3R,4R,5R)-6-(((2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexane-1,2,3,4,5-pentaol, 97.0%, 1g

2,3-Dihydro-1,4-dithiino[2,3-c]furan-5,7-dione, 98.0%, 5g

Methyl 2-methyl-2H-indazole-4-carboxylate, 95.0%, 100mg

Reaktionsgefäße m. Schraubver., PP, steril, konisch, 1,5 ml, 500 Stück

(4-Amino-3-bromophenyl)acetonitrile, 97.0%, 5g

4-Chloro-2-[4-(tetrahydro-pyran-4-yl)-piperidin-1-ylmethyl]-phenol, 1g

3-Cyano-5-methylbenzoic acid, 95.0%, 250mg

(S)-3-((TERT-BUTOXYCARBONYL)AMINO)-3-(3-NITROPHENYL)PROPANOIC ACID, 95.0%, 1g